Food and Drug Administration (FDA) released the following Class I recall information in its January 30, 2002 Enforcement Report
BPC-157 is unusually stable in gastric acid, which is why an oral route is even plausible for a peptide most peptides are destroyed in the stomach
The standard GLOW protocol ratio is 5:1:1 for GHK-Cu:TB-500:BPC-157 by weight, reflecting GHK-Cus lower potency requiring higher doses to achieve comparable tissue effects
Adjustment of treatment frequency based on clinical assessment and laboratory results
However, broad inhibition of NF-B would cause side effects, and further studies are needed to target specific tissue
B12 is found naturally in foods such as meat, fish, eggs, dairy products, and certain fortified foods